Online inquiry

IVTScrip™ mRNA-Anti-KDR, Angiocept(Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) (CAT#: GTTS-WQ2995MR)

This product GTTS-WQ2995MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methoxy-UTP. It ecodes the monoclonal antibody that targets KDR gene. The antibody can be applied in Colorectal Cancer (CRC) research.

Specifications
Product type	mRNA
Modified bases	5-Methoxy-UTP
5' Cap	Cap 0
Species	Homo sapiens
RefSeq	NM_002253.4
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	3791
UniProt ID	P35968

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-KDR, Angiocept(Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) (GTTS-WQ2995MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ3138MR	IVTScrip™ mRNA-Anti-C3&C4, APT070(Cap 1, Pseudo-UTP, 120 nt-poly(A))	mRNA	APT070
GTTS-WQ1353MR	IVTScrip™ mRNA-Anti-EGFR, ABT-806(Cap 0, 5-Methyl-CTP, 30 nt-poly(A))	mRNA	ABT-806
GTTS-WQ15667MR	IVTScrip™ mRNA-Anti-EPCAM, VB6-845(Cap 0, 5-Methoxy-UTP, 120 nt-poly(A))	mRNA	VB6-845
GTTS-WQ9051MR	IVTScrip™ mRNA-Anti-FLT1, IMC-18F1(Cap 0, Pseudo-UTP, 120 nt-poly(A))	mRNA	IMC-18F1
GTTS-WQ3762MR	IVTScrip™ mRNA-Anti-CEACAM6, BAY-1834942(Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	BAY-1834942
GTTS-WQ15816MR	IVTScrip™ mRNA-Anti-CD3E&IL3RA, XmAb14045(Cap 1, 5-Methoxy-UTP, 120 nt-poly(A))	mRNA	XmAb14045
GTTS-WQ3533MR	IVTScrip™ mRNA-Anti-APP, BART(Cap 0, 5-Methyl-CTP, 30 nt-poly(A))	mRNA	BART
GTTS-WQ8191MR	IVTScrip™ mRNA-Anti-FCGRT, HL161(Cap 0, 5-Methyl-CTP, 120 nt-poly(A))	mRNA	HL161

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST